205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
20.87%
Net income growth 1.25-1.5x MCHP's 14.67%. Bruce Berkowitz would verify whether cost discipline or revenue gains drive the outperformance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
3700.00%
Some yoy increase while MCHP is negative at -50.00%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
68.24%
Some CFO growth while MCHP is negative at -57.43%. John Neff would note a short-term liquidity lead over the competitor.
-34.08%
Both yoy lines negative, with MCHP at -13.56%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-43.90%
Negative yoy purchasing while MCHP stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-33.96%
We reduce yoy sales while MCHP is 3700.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
No Data
No Data available this quarter, please select a different quarter.
-200.84%
We reduce yoy invests while MCHP stands at 7.39%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
50.00%
Lower share issuance yoy vs. MCHP's 1300.00%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
No Data
No Data available this quarter, please select a different quarter.